These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 6194310)
1. Characterization of a herpes simplex virus type 2 75,000-molecular-weight glycoprotein antigenically related to herpes simplex virus type 1 glycoprotein C. Zezulak KM; Spear PG J Virol; 1983 Sep; 47(3):553-62. PubMed ID: 6194310 [TBL] [Abstract][Full Text] [Related]
2. Endo-beta-N-acetylglucosaminidase H sensitivity of precursors to herpes simplex virus type 1 glycoproteins gB and gC. Wenske EA; Bratton MW; Courtney RJ J Virol; 1982 Oct; 44(1):241-8. PubMed ID: 6292487 [TBL] [Abstract][Full Text] [Related]
3. Identification of an Epstein-Barr virus glycoprotein which is antigenically homologous to the varicella-zoster virus glycoprotein II and the herpes simplex virus glycoprotein B. Emini EA; Luka J; Armstrong ME; Keller PM; Ellis RW; Pearson GR Virology; 1987 Apr; 157(2):552-5. PubMed ID: 3029988 [TBL] [Abstract][Full Text] [Related]
4. Herpes simplex virus type 2 glycoprotein gF and type 1 glycoprotein gC have related antigenic determinants. Zweig M; Showalter SD; Bladen SV; Heilman CJ; Hampar B J Virol; 1983 Jul; 47(1):185-92. PubMed ID: 6191040 [TBL] [Abstract][Full Text] [Related]
5. Epitopes of herpes simplex virus type 1 glycoprotein gC are clustered in two distinct antigenic sites. Marlin SD; Holland TC; Levine M; Glorioso JC J Virol; 1985 Jan; 53(1):128-36. PubMed ID: 2578193 [TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to two glycoproteins of herpes simplex virus type 2. Balachandran N; Harnish D; Killington RA; Bacchetti S; Rawls WE J Virol; 1981 Aug; 39(2):438-46. PubMed ID: 6168775 [TBL] [Abstract][Full Text] [Related]
7. Inhibition of glycosylation of herpes simplex virus glycoproteins: identification of antigenic and immunogenic partially glycosylated glycopeptides on the cell surface membrane. Glorioso J; Szczesiul MS; Marlin SD; Levine M Virology; 1983 Apr; 126(1):1-18. PubMed ID: 6189286 [TBL] [Abstract][Full Text] [Related]
8. Antibodies to a synthetic oligopeptide that react with herpes simplex virus type 1 and 2 glycoprotein C. Zweig M; Showalter SD; Simms DJ; Hampar B J Virol; 1984 Aug; 51(2):430-6. PubMed ID: 6086954 [TBL] [Abstract][Full Text] [Related]
9. Relatedness of glycoproteins expressed on the surface of simian herpes-virus virions and infected cells to specific HSV glycoproteins. Eberle R; Black D; Hilliard JK Arch Virol; 1989; 109(3-4):233-52. PubMed ID: 2482016 [TBL] [Abstract][Full Text] [Related]
10. Induction of neutralizing antibody against varicella-zoster virus (VZV) by VZV gp3 and cross-reactivity between VZV gp3 and herpes simplex viruses gB. Kitamura K; Namazue J; Campo-Vera H; Ogino T; Yamanishi K Virology; 1986 Feb; 149(1):74-82. PubMed ID: 2418583 [TBL] [Abstract][Full Text] [Related]
11. Type-common CP-1 antigen of herpes simplex virus is associated with a 59,000-molecular-weight envelope glycoprotein. Cohen GH; Katze M; Hydrean-Stern C; Eisenberg RJ J Virol; 1978 Jul; 27(1):172-81. PubMed ID: 80458 [TBL] [Abstract][Full Text] [Related]
12. Glycoproteins of herpes simplex virus type 2 as defined by monoclonal antibodies. Balachandran N; Harnish D; Rawls WE; Bacchetti S J Virol; 1982 Oct; 44(1):344-55. PubMed ID: 6292496 [TBL] [Abstract][Full Text] [Related]
13. Effect of tunicamycin on the synthesis of herpes simplex virus type 1 glycoproteins and their expression on the cell surface. Norrild B; Pedersen B J Virol; 1982 Aug; 43(2):395-402. PubMed ID: 6180176 [TBL] [Abstract][Full Text] [Related]
14. A rapid procedure for the enrichment of undenaturated, antigenically active herpes simplex virus glycoproteins. Respess RA; Pancake BA; Edson CM; Schaffer PA J Virol Methods; 1984 Feb; 8(1-2):27-45. PubMed ID: 6200489 [TBL] [Abstract][Full Text] [Related]
15. Processing of N-linked oligosaccharides from precursor- to mature-form herpes simplex virus type 1 glycoprotein gC. Serafini-Cessi F; Dall'Olio F; Pereira L; Campadelli-Fiume G J Virol; 1984 Sep; 51(3):838-44. PubMed ID: 6088806 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and processing of glycoprotein gG of herpes simplex virus type 2. Balachandran N; Hutt-Fletcher LM J Virol; 1985 Jun; 54(3):825-32. PubMed ID: 2987534 [TBL] [Abstract][Full Text] [Related]
17. Novel herpes simplex virus type 1 glycoproteins identified by antiserum against a synthetic oligopeptide from the predicted product of gene US4. Frame MC; Marsden HS; McGeoch DJ J Gen Virol; 1986 Apr; 67 ( Pt 4)():745-51. PubMed ID: 3007661 [TBL] [Abstract][Full Text] [Related]
18. Glycosylation of herpes simplex virus type 1 gC in the presence of tunicamycin. Wenske EA; Courtney RJ J Virol; 1983 Apr; 46(1):297-301. PubMed ID: 6298464 [TBL] [Abstract][Full Text] [Related]
19. Human natural killer cell recognition of herpes simplex virus type 1 glycoproteins: specificity analysis with the use of monoclonal antibodies and antigenic variants. Bishop GA; Marlin SD; Schwartz SA; Glorioso JC J Immunol; 1984 Oct; 133(4):2206-14. PubMed ID: 6206157 [TBL] [Abstract][Full Text] [Related]
20. Structural analysis of precursor and product forms of type-common envelope glycoprotein D (CP-1 antigen) of herpes simplex virus type 1. Eisenberg RJ; Hydrean-Stern C; Cohen GH J Virol; 1979 Sep; 31(3):608-20. PubMed ID: 229243 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]